Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
NUVB
#3996
Nuvation Bio Inc.
5.9
2
+5.71%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+5.71%
Monatliche Änderung
+5.53%
6 month change
+98.66%
Jahresänderung
+203.59%
Vorheriger Schlusskurs
5.6
0
Open
5.7
9
Bid
Ask
Low
5.7
9
High
5.9
2
Volumen
1 640
Märkte
Aktien
Gesundheitswesen
NUVB
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
335.25 M
337.68 M
336.84 M
336.84 M
336.84 M
—
Valuation ratios
Enterprise value
740.7 M
1.77 B
656.57 M
472.02 M
1.22 B
4.12 B
Price to earnings ratio
-1
-1.26
-0.77
-4.06
-7.55
-13.64
Price to sales ratio
0.29
0.09
0.05
0.04
0.04
0.22
Price to cash flow ratio
0.01
0.01
0
0
0.01
0.02
Price to book ratio
0
0
0
0
0
0
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.07
-0.09
-0.11
-0.09
-0.09
-0.38
Return on equity %
-0.08
-0.11
-0.13
-0.16
-0.17
-0.56
Return on invested capital %
-608.13
-683.06
-687.1
-642.14
-511.99
-2 524.3
Gross margin %
84.18
26.18
32.1
46.7
74.47
179.45
Operating margin %
-6 616.37
-944.53
-1 913.23
-1 315.73
-430.14
-4 603.62
EBITDA margin %
—
—
—
—
-428.51
—
Net margin %
-5 668.5
-865.79
-1 726.2
-1 220.92
-425.24
-4 238.15
Liquidity ratios
Quick ratio
—
—
9.01
9.38
8.39
—
Current ratio
9.57
9.04
9.01
9.39
8.48
35.92
Inventory turnover
—
—
149.57
9.1
1.07
—
Asset turnover
0
0.01
0.01
0.01
0.02
0.05
Solvency ratios
Debt to assets ratio
—
—
0.21
0.08
0.09
—
Debt to equity ratio
—
—
0.25
0.14
0.16
—
Long term debt to total assets ratio
—
—
0.2
0.07
0.08
—
Long term debt to total equity ratio
—
—
0.24
0.13
0.14
—
Per share metrics
Operating cash flow per share
-126.42
-172.27
-125.89
-141.83
-155.28
-595.27
EBIT per share
-195.62
-200.7
-174.25
-187.2
-165.69
-727.84
EBITDA per share
—
—
—
—
-165.07
—
Total debt per share
—
—
312.11
154.72
154.75
—
Cash per share
2 233.3
1 870.33
1 363.44
1 789.08
1 612.01
6 634.85
Net current asset value per share
2 297.76
1 958
1 404.46
1 834.66
1 695.64
6 892.76
Tangible book value per share
2 033.21
1 708.38
1 225.74
1 062.05
922.5
4 918.68
Working capital per share
2 057.67
1 741.29
1 248.61
1 639.32
1 495.61
6 124.83
Book value per share
2 044.51
1 725.58
1 238.76
1 097.8
956.8
5 018.94
Nachrichten
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update
Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma
Starkes Umsatzwachstum bei Ibtrozi: B.Riley bekräftigt "Buy"-Rating für Nuvation Bio
Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)
Nuvation Bio: Truist Securities erhöht Kursziel wegen starker Ibtrozi-Nachfrage auf 13 US-Dollar
Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake
Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study
Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround
Nuvation Bio stock price target lowered to $17 at H.C. Wainwright
Nuvation Bio: Citizens bestätigt "Market Outperform"-Rating und Kursziel von 10 US-Dollar